Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn

ISSN:
1432-1041
Keywords:
Theophylline ; kinetics ; apnea ; premature newborns ; developmental pharmacology
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
Medicine
Notes:
Summary Aminophylline (theophylline-ethylenediamine) was administered to 27 premature newborns to prevent apneic spells. Of the 22 patients monitored for theophylline concentration, a therapeutic blood level was reached in 19 in 1–2 days, and 3 stayed below it. ‘Toxic’ blood levels (≥20 µg/ml) were reached in 3 cases, one of whom showed signs of toxicity. Theophylline treatment was not efficient in the prevention of apnea when a serious underlying disease was present. Theophylline blood half-life (mean : 27.0 h) and clearance (mean 12.9 ml/h/kg) confirmed the slow elimination pattern of the drug in the premature infant.
Type of Medium:
Electronic Resource
URL:
_version_ 1798295564698255360
autor Latini, R.
Assael, B. M.
Bonati, M.
Caccamo, M. L.
Gerna, M.
Mandelli, M.
Marini, A.
Sereni, F.
Tognoni, G.
autorsonst Latini, R.
Assael, B. M.
Bonati, M.
Caccamo, M. L.
Gerna, M.
Mandelli, M.
Marini, A.
Sereni, F.
Tognoni, G.
book_url http://dx.doi.org/10.1007/BF00609983
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM202429199
issn 1432-1041
journal_name European journal of clinical pharmacology
materialart 1
notes Summary Aminophylline (theophylline-ethylenediamine) was administered to 27 premature newborns to prevent apneic spells. Of the 22 patients monitored for theophylline concentration, a therapeutic blood level was reached in 19 in 1–2 days, and 3 stayed below it. ‘Toxic’ blood levels (≥20 µg/ml) were reached in 3 cases, one of whom showed signs of toxicity. Theophylline treatment was not efficient in the prevention of apnea when a serious underlying disease was present. Theophylline blood half-life (mean : 27.0 h) and clearance (mean 12.9 ml/h/kg) confirmed the slow elimination pattern of the drug in the premature infant.
package_name Springer
publikationsjahr_anzeige 1978
publikationsjahr_facette 1978
publikationsjahr_intervall 8024:1975-1979
publikationsjahr_sort 1978
publisher Springer
reference 13 (1978), S. 203-207
schlagwort Theophylline
kinetics
apnea
premature newborns
developmental pharmacology
search_space articles
shingle_author_1 Latini, R.
Assael, B. M.
Bonati, M.
Caccamo, M. L.
Gerna, M.
Mandelli, M.
Marini, A.
Sereni, F.
Tognoni, G.
shingle_author_2 Latini, R.
Assael, B. M.
Bonati, M.
Caccamo, M. L.
Gerna, M.
Mandelli, M.
Marini, A.
Sereni, F.
Tognoni, G.
shingle_author_3 Latini, R.
Assael, B. M.
Bonati, M.
Caccamo, M. L.
Gerna, M.
Mandelli, M.
Marini, A.
Sereni, F.
Tognoni, G.
shingle_author_4 Latini, R.
Assael, B. M.
Bonati, M.
Caccamo, M. L.
Gerna, M.
Mandelli, M.
Marini, A.
Sereni, F.
Tognoni, G.
shingle_catch_all_1 Latini, R.
Assael, B. M.
Bonati, M.
Caccamo, M. L.
Gerna, M.
Mandelli, M.
Marini, A.
Sereni, F.
Tognoni, G.
Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
Theophylline
kinetics
apnea
premature newborns
developmental pharmacology
Theophylline
kinetics
apnea
premature newborns
developmental pharmacology
Summary Aminophylline (theophylline-ethylenediamine) was administered to 27 premature newborns to prevent apneic spells. Of the 22 patients monitored for theophylline concentration, a therapeutic blood level was reached in 19 in 1–2 days, and 3 stayed below it. ‘Toxic’ blood levels (≥20 µg/ml) were reached in 3 cases, one of whom showed signs of toxicity. Theophylline treatment was not efficient in the prevention of apnea when a serious underlying disease was present. Theophylline blood half-life (mean : 27.0 h) and clearance (mean 12.9 ml/h/kg) confirmed the slow elimination pattern of the drug in the premature infant.
1432-1041
14321041
Springer
shingle_catch_all_2 Latini, R.
Assael, B. M.
Bonati, M.
Caccamo, M. L.
Gerna, M.
Mandelli, M.
Marini, A.
Sereni, F.
Tognoni, G.
Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
Theophylline
kinetics
apnea
premature newborns
developmental pharmacology
Theophylline
kinetics
apnea
premature newborns
developmental pharmacology
Summary Aminophylline (theophylline-ethylenediamine) was administered to 27 premature newborns to prevent apneic spells. Of the 22 patients monitored for theophylline concentration, a therapeutic blood level was reached in 19 in 1–2 days, and 3 stayed below it. ‘Toxic’ blood levels (≥20 µg/ml) were reached in 3 cases, one of whom showed signs of toxicity. Theophylline treatment was not efficient in the prevention of apnea when a serious underlying disease was present. Theophylline blood half-life (mean : 27.0 h) and clearance (mean 12.9 ml/h/kg) confirmed the slow elimination pattern of the drug in the premature infant.
1432-1041
14321041
Springer
shingle_catch_all_3 Latini, R.
Assael, B. M.
Bonati, M.
Caccamo, M. L.
Gerna, M.
Mandelli, M.
Marini, A.
Sereni, F.
Tognoni, G.
Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
Theophylline
kinetics
apnea
premature newborns
developmental pharmacology
Theophylline
kinetics
apnea
premature newborns
developmental pharmacology
Summary Aminophylline (theophylline-ethylenediamine) was administered to 27 premature newborns to prevent apneic spells. Of the 22 patients monitored for theophylline concentration, a therapeutic blood level was reached in 19 in 1–2 days, and 3 stayed below it. ‘Toxic’ blood levels (≥20 µg/ml) were reached in 3 cases, one of whom showed signs of toxicity. Theophylline treatment was not efficient in the prevention of apnea when a serious underlying disease was present. Theophylline blood half-life (mean : 27.0 h) and clearance (mean 12.9 ml/h/kg) confirmed the slow elimination pattern of the drug in the premature infant.
1432-1041
14321041
Springer
shingle_catch_all_4 Latini, R.
Assael, B. M.
Bonati, M.
Caccamo, M. L.
Gerna, M.
Mandelli, M.
Marini, A.
Sereni, F.
Tognoni, G.
Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
Theophylline
kinetics
apnea
premature newborns
developmental pharmacology
Theophylline
kinetics
apnea
premature newborns
developmental pharmacology
Summary Aminophylline (theophylline-ethylenediamine) was administered to 27 premature newborns to prevent apneic spells. Of the 22 patients monitored for theophylline concentration, a therapeutic blood level was reached in 19 in 1–2 days, and 3 stayed below it. ‘Toxic’ blood levels (≥20 µg/ml) were reached in 3 cases, one of whom showed signs of toxicity. Theophylline treatment was not efficient in the prevention of apnea when a serious underlying disease was present. Theophylline blood half-life (mean : 27.0 h) and clearance (mean 12.9 ml/h/kg) confirmed the slow elimination pattern of the drug in the premature infant.
1432-1041
14321041
Springer
shingle_title_1 Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
shingle_title_2 Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
shingle_title_3 Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
shingle_title_4 Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:38:12.780Z
titel Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
titel_suche Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
topic V
WW-YZ
uid nat_lic_papers_NLM202429199